M
Mount Logan Capital Inc.
MLCICIK 0002051820NasdaqEmerging GrowthInvestment AdviceDelawareFY ends Dec 31
Period
FY 2025
Revenue
$53.57M
Net Income
$-60.85M
Total Assets
$1.60B
Equity
$90.96M
Shares Out
11.20M
Op. Cash Flow
$-22.18M
Business
Mount Logan Capital Inc. is a publicly listed company in Investment Advice, incorporated in Delaware. Common stock trades on Nasdaq under the ticker MLCI.
Auto-generated from company profile
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 |
|---|---|---|---|
| Equity investment earning | 1 | 680,000 | |
| Net premiums | −17 | −15 | |
| Total revenues | 54 | 50 | |
| Amortization of deferred acquisition costs | 3 | 2 | |
| Goodwill impairment | 26 | 0 | |
| Total expenses | 121 | 60 | |
| Income (loss) before taxes | −58 | −10 | |
| Net income (loss) | −61 | −10 | |
| Net income (loss) attributable to common shareholders - basic (in dollars per share) | −7.08 | −1.7 | |
| Net income (loss) attributable to common shareholders - Diluted (in dollars per share) | −7.08 | −1.7 | |
| Weighted average shares outstanding Basic (in shares) | 9 | 6 | |
| Weighted average shares outstanding Diluted (in shares) | 9 | 6 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Investments | 1,107 | 1,063 | — | |
| Reinsurance recoverable | 273 | 259 | — | |
| Deferred acquisition costs | 7 | 7 | 6 | |
| Goodwill | 30 | 56 | — | |
| Other assets | 26 | 47 | — | |
| Assets | 1,601 | 1,562 | — | |
| Future policy benefits | 782 | 770 | — | |
| Accrued expenses and other liabilities | 20 | 9 | — | |
| Liabilities | 1,510 | 1,458 | — | |
| Commitments and Contingencies | — | — | — | |
| Common shares | 13,000 | 6,000 | — | |
| Warrants | 1 | 1 | — | |
| Additional paid-in-capital | 177 | 124 | — | |
| Retained earnings (accumulated deficit) | −121 | −58 | — | |
| Accumulated other comprehensive income (loss) | 33 | 37 | — | |
| Total equity | 91 | 104 | 105 | |
| Total liabilities and equity | 1,601 | 1,562 | — |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 |
|---|---|---|---|
| Net realized (gains) losses on investments | 3 | −226,000 | |
| Net realized (gains) losses on foreign currency | 5,000 | 5,000 | |
| Net change in unrealized (gains) losses on investments | −12 | 8 | |
| Net change in unrealized (gains) losses on foreign currency | −37,000 | 62,000 | |
| Change in fair value of debt obligation | −1 | 296,000 | |
| Payment in-kind interest | −5 | −3 | |
| Amortization of debt issuance costs | 504,000 | 359,000 | |
| Amortization of intangible assets | 4 | 2 | |
| Impairment of intangible assets | 11 | 2 | |
| Net amortization of premiums and accretion of discounts on investments | −287,000 | −625,000 | |
| Equity based compensation | 2 | 468,000 | |
| Increase (decrease) in estimated credit losses | 4 | 4 | |
| Gain on reverse acquisition of business | −4 | 0 | |
| Reinsurance recoverable | 6 | 17 | |
| Change in deferred acquisition costs | −3 | −2 | |
| Distributions from equity method investments | 1 | 2 | |
| Purchases of investments by consolidated VIEs | −92 | −118 | |
| Proceeds from sale of investments by consolidated VIEs | 96 | 116 | |
| Due to related parties | 1 | −2 | |
| Future policy benefits | −21 | −35 | |
| Interest sensitive contract liabilities | 16 | 15 | |
| Funds held under reinsurance contracts | −3 | 2 | |
| Accrued expenses and other liabilities | 4 | −25 | |
| Net cash used in operating activities | −22 | −38 | |
| Purchases of investments | −304 | −317 | |
| Proceeds received from reverse acquisition of business | 37 | 0 | |
| Proceeds from sales and repayments of investments | 318 | 291 | |
| Net cash provided by (used in) investing activities | 51 | −26 | |
| Shareholder dividends | −2 | −2 | |
| Repurchase of common shares | −1 | 0 | |
| Proceeds from borrowings of asset management business | 3 | 32 | |
| Repayments of borrowings of asset management business | −2 | −17 | |
| Financing costs paid and deferred | 0 | −270,000 | |
| Proceeds from borrowings of insurance business | 3 | 0 | |
| Deposits on investment-type policies and contracts | 43 | 73 | |
| Withdrawals on investment-type policies and contracts | −30 | −9 | |
| Net cash provided by (used in) financing activities | 13 | 76 | |
| Interest received | 79 | 91 | |
| Interest paid | 7 | 5 | |
| Dividends received | 1 | 2 | |
| Income taxes paid | 307,000 | 828,000 | |
| Cashless repayment on borrowings | 0 | 14 | |
| Restricted stock release (in shares) | 2 | 511,000 | |
| Issuance of common shares for investment purchases (in shares) | 53 | 0 | |
| Issuance of common shares for share based compensation | 45,000 | 0 |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro